Matthew Rizzo Xtant Medical Holdings, Inc. (XTNT) insider trading activity

XTNT Quotes by TradingView

Matthew Rizzo is Director of Xtant Medical Holdings, Inc.. Currently has a direct ownership of 215,415 shares of XTNT, which is worth approximately $114,169. The most recent transaction as insider was on Aug 15, 2022, when has been sold 215,415 shares (Common Stock, $0.000001 par value) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 215K
0% 3M change
0% 12M change
Total Value Held $114,169

Matthew Rizzo Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 15 2022
BUY
Grant, award, or other acquisition
-
215,415 Added 50.0%
215,415 Common Stock, $0.00000...
Aug 15 2021
BUY
Grant, award, or other acquisition
-
85,337 Added 41.45%
120,549 Common Stock
MR

Matthew Rizzo

Director
Belgrade, MT

Track Institutional and Insider Activities on XTNT

Follow Xtant Medical Holdings, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells XTNT shares.

Notify only if

Insider Trading

Get notified when an Xtant Medical Holdings, Inc. insider buys or sells XTNT shares.

Notify only if

News

Receive news related to Xtant Medical Holdings, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on XTNT